Serge Stankovic

Track

Insider profile

Currently holds a position at ACADIA Pharmaceuticals Inc

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 59% 68% 82%
Transactions
14 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President ACADIA Pharmaceuticals Inc Nov. 19, 2018 -
Executive Vice President, Head - Research and Development ACADIA Pharmaceuticals Inc Nov. 30, 2015 - Nov. 19, 2018
Senior Vice President - Clinical Development Alkermes Plc Sept. 30, 2013 - March 31, 2014
Serge Stankovic's trades of ACADIA Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-22 2022-11-21
S Sale
39,921 -32.2%
287.58
US$869,088 		39,921 -32.2% 287.58 US$869,088
2022-10-18 2022-10-15
S Sale
18,093 +41.9%
319.47
US$1,038,018 		18,093 +41.9% 319.47 US$1,038,018
2022-05-03 2022-05-02
S Sale
3,283 -20.8%
311.07
US$3,397,889 		3,283 -20.8% 311.07 US$3,397,889
2022-02-25 2022-02-23
S Sale
1,501 -3.0%
23.80
US$35,724 		1,501 -3.0% 23.80 US$35,724
2022-01-10 2022-01-06
S Sale
1,937 -4.1%
23.05
US$44,648 		1,937 -4.1% 23.05 US$44,648
2021-11-23 2021-11-22
S Sale
2,803 -6.3%
19.01
US$53,285 		2,803 -6.3% 19.01 US$53,285
2021-10-19 2021-10-18
S Sale
1,338 -3.4%
17.41
US$23,295 		1,338 -3.4% 17.41 US$23,295
2021-04-30 2021-04-30
S Sale
4,230 -10.4%
20.33
US$85,996 		4,230 -10.4% 20.33 US$85,996
2021-02-08 2021-02-04
S Sale
8,429 -21.4%
50.61
US$426,592 		8,429 -21.4% 50.61 US$426,592
2021-01-14 2021-01-12
PlS Planned sale
700 -3.3%
55.01
US$38,507 		700 -3.3% 55.01 US$38,507
2021-01-08 2021-01-08
PlS Planned sale
29,733 -59.5%
55.22
US$1,641,832 		29,733 -59.5% 55.22 US$1,641,832
2021-01-08 2021-01-07
PlS Planned sale
61,619 -75.3%
55.12
US$3,396,187 		61,619 -75.3% 55.12 US$3,396,187
2021-01-08 2021-01-06
S Sale
1,725 -7.9%
53.34
US$92,012 		1,725 -7.9% 53.34 US$92,012
2020-11-20 2020-11-20
S Sale
2,728 -14.2%
53.50
US$145,948 		2,728 -14.2% 53.50 US$145,948
2020-10-19 2020-10-16
S Sale
1,297 -9.1%
42.56
US$55,200 		1,297 -9.1% 42.56 US$55,200
2020-06-19 2020-06-19
PlS Planned sale
16,452 -59.2%
50.12
US$824,515 		16,452 -59.2% 50.12 US$824,515
2020-06-19 2020-06-18
PlS Planned sale
65,843 -85.3%
50.01
US$3,292,729 		65,843 -85.3% 50.01 US$3,292,729
2020-05-01 2020-04-30
S Sale
4,308 -27.5%
49.21
US$211,997 		4,308 -27.5% 49.21 US$211,997
2020-04-24 2020-04-23
PlS Planned sale
18,949 -75.9%
50.07
US$948,729 		18,949 -75.9% 50.07 US$948,729
2020-04-22 2020-04-22
PlS Planned sale
54,019 -90.0%
50.02
US$2,701,906 		54,019 -90.0% 50.02 US$2,701,906
2020-04-22 2020-04-20
PlS Planned sale
100,000 -94.3%
50.15
US$5,015,450 		100,000 -94.3% 50.15 US$5,015,450
2019-10-17 2019-10-15
S Sale
1,031 -34.7%
39.65
US$40,879 		1,031 -34.7% 39.65 US$40,879